Considering the increasing use of sugammadex worldwide, we acknowledge the need to warn the medical community that the risk of recurarization is high in many parts of the world. We call for clinical attention to prevent recurarization, anaphylactic reactions, and other postoperative complications associated with using muscle relaxants and their antagonists based on neuromuscular monitoring.
More About Scientific Programme
Blind Spot in Patient Safety – Safety II
by Della Lin MS, MD, FASA
With COVID-19, we saw a swift degradation of patient safety. This suggests that…